Dr. Tuerk’s current research focuses on training and augmenting evidence based treatment for childhood OCD via the development of specialized crowd-sourcing and asynchronous telehealth technologies, and the development of artificial intelligence (AI) and virtual reality (VR) technologies for the treatment of childhood social and school anxiety. Since joining the Curry faculty in June of 2018 he has been working on structuring the Sheila C. Johnson Center to optimize multidisciplinary training and research related to the provision of evidence based clinical services for area children, families, and adults.
Featured Current Contributions
Tuerk, P. W., Rauch, S. A., & Rothbaum, B. O. (2019). Effect size matters: a key neglected indicator of comparative trial quality. The Lancet Psychiatry, 6 (2), e4.
Rauch, S. A., Kim, H. M., Powell, C., Tuerk, P. W., ... & Stein, M. B. (2019). Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry, 76 (2), 117-126.
Tuerk, P. W., Keller, S. M., & Acierno, R. (2018). Treatment for Anxiety and Depression via Clinical Videoconferencing: Evidence Base and Barriers to Expanded Access in Practice. Focus, 16 (4), 363-369.
Tuerk, P. W., Wangelin, B. C., Powers, M. B.,... & Hamner, M. B. (2018). Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cognitive Behaviour Therapy, 47 (5), 1-21.
Tuerk, P.W., Schaeffer, C.M., McGuire, J.F.,.., Piacentini, J. (in press). Adapting Evidence-Based Treatments for Digital Technologies: A Critical Review of Functions, Tools, and the Use of Branded Solutions. Current Psychiatry Reports.